Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen (Q41588927)

4 October 2017

Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A441430

1 July 2022

Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen (English)

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

11 May 2023

author name string

A. Bennett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A441430

1 July 2022

J. Houghton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A441430

1 July 2022

D. J. Leaper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A441430

1 July 2022

I. F. Stamford

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A441430

1 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=441430

1 July 2022

publication date

1 February 1979

1 reference

full work available at URL

4 October 2017

https://api.elsevier.com/content/article/PII:0090698079900376?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

https://api.elsevier.com/content/article/PII:0090698079900376?httpAccept=text/plain

11 May 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

11 May 2023

1 reference

4 October 2017

17

1 reference

4 October 2017

2

1 reference

4 October 2017

179-191

1 reference

Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit

4 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Prostaglandins E and F in Endocrine Diarrheagenic Syndromes

11 May 2023

2

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma

11 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice

11 May 2023

4

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Subversion of immune system by tumor cells and role of prostaglandins

11 May 2023

5

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse

11 May 2023

6

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Enhancement of carcinogenesis by prostaglandins

11 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Human breast tumour-induced osteolysis and prostaglandins

11 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins

11 May 2023

9

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer

11 May 2023

10

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Breast cancer, prostaglandins, and bone metastases

11 May 2023

11

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Bone destruction by breast tumours

11 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Prostaglandins and breast cancer

11 May 2023

13

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin

11 May 2023

14

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Treatment of radiation-induced gastrointestinal distress with acetylsalicylate

11 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

11 May 2023

17

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

The Effect on Cell Survival of Inhalation of Oxygen under High Pressure During Irradiationin vivoof a Solid Mouse Sarcoma

11 May 2023

18

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Prostaglandin E2 and gastric acid secretion in man.

11 May 2023

19

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Extraction of Prostaglandins from Human Blood

11 May 2023

20

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

11 May 2023

21

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Effect of ionizing radiation on prostaglandin-like activity in tissues

11 May 2023

22

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

Inhibition of tumour growth in vivo and in vitro by prostaglandin E

11 May 2023

25

1 reference

https://api.crossref.org/works/10.1016/0090-6980(79)90037-6

11 May 2023

Identifiers

1 reference

4 October 2017

1 reference